简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Cognyte Software宣布与亚太地区的一家长期军事情报客户达成价值超过500万美元的后续协议,以扩大其对Cognyte战术信号情报解决方案的使用

2025-10-22 20:04

Cognyte Software Ltd. (NASDAQ:CGNT) ("Cognyte"), a global leader in software-driven technology for investigative analytics, today announced a follow-on agreement valued at over $5 million with a long-standing military intelligence customer in the Asia-Pacific (APAC) region. The customer, which has partnered with Cognyte for more than a decade, is expanding its deployment to an additional frontline military unit to protect its national interests and enhance operational efficiency with tactical SIGINT solutions for border security.

Built on years of proven operational success, this expansion shows customer trust and value in action and advances Cognyte's land-and-expand strategy through reoccurring business. The new deployment equips the unit with advanced analytical capabilities that enhance mission readiness and support secure decision making across tactical operational environments. The capabilities bolster monitoring across complex border areas and help to prevent potential evolving threats to national security.

"Our ability to land customers, quickly prove value and then continuously expand within them is a key driver of our growth," said David Abadi, Chief Financial Officer at Cognyte. "This follow-on contract reflects that strategy in action, demonstrating how our deep-rooted customer relationships and proven technology translate into repeatable, follow-on business and support our goal of sustained, long-term growth."

"This agreement also underscores the trust and confidence that our long-term customers place in Cognyte," said Efi Nuri, Chief Revenue Officer at Cognyte. "Our solutions continue to deliver operational impact, leading to further expansions into new departments and units. It's a clear demonstration of how Cognyte's technology and customer-centric approach translate into lasting value and stronger partnerships."

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。